Document is current
Any future updates will be listed below
-
Authors
Carollo, Massimo https://orcid.org/0000-0002-6523-6036
Boccardi, Virginia https://orcid.org/0000-0003-2134-1122
Crisafulli, Salvatore https://orcid.org/0000-0001-6625-1943
Conti, Valeria https://orcid.org/0000-0001-6964-2739
Gnerre, Paola https://orcid.org/0000-0002-1397-6059
Miozzo, Simonetta
Omodeo Salè, Emanuela https://orcid.org/0000-0002-7641-8708
Pieraccini, Fabio
Zamboni, Mauro https://orcid.org/0000-0001-6961-9483
Marengoni, Alessandra https://orcid.org/0000-0002-4851-1825
Onder, Graziano https://orcid.org/0000-0003-3400-4491
Trifirò, Gianluca https://orcid.org/0000-0003-1147-7296
,
Antonioni, Raffaella
Selleri, Margherita
Vitturi, Giacomo
Filippelli, Amelia
Corrao, Salvatore
Medea, Gerardo
Nobili, Alessandro
Pasina, Luca
Salé, Emanuela Omodeo
Petraglia, Francesco Maria
Poluzzi, Elisabetta
Valle, Alessandro
Vercellone, Adriano
Veronese, Nicola
-
Funding
Funding for this research was provided by:
Università degli Studi di Verona
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 17 December 2023
First Online: 8 March 2024
Declarations
:
: GT has served in the last 3 years on advisory boards/seminars funded by Sanofi, Eli Lilly, AstraZeneca, Abbvie, Novo Nordisk, Gilead, and Amgen; he is also a scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding for conducting observational studies from several pharmaceutical companies. None of these listed activities is related to the topic of the article. The other authors have no competing interests to declare that are relevant to the content of this article.
: This article does not contain any studies with human participants or animals performed by any authors.
: Not applicable.
: For this type of study, formal consent is not required.
